Primo Biotechnology Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$7.43M
- Investors
-
2
Primo Biotechnology General Information
Description
Operator of a molecular imaging platform intended to provide an accurate diagnosis of cancer. The company's platform specializes in non-invasive radiopharmaceutical imaging technology to detect early-stage colorectal cancer, esophageal cancer, and lung adenocarcinoma, enabling doctors to make informed decisions, personalize and expedite cancer care.
Contact Information
Website
www.primobt.comCorporate Office
- 14F, No. 167, Dunhua North Road, Songshan District
- Taipei City
- Taiwan
Corporate Office
- 14F, No. 167, Dunhua North Road, Songshan District
- Taipei City
- Taiwan
Primo Biotechnology Timeline
Primo Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 02-Jul-2025 | $7.43M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-Jan-2023 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Primo Biotechnology Patents
Primo Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240123097-A1 | Dual-mode pharmaceutical composition for peptide-specific targeted positron emission tomography and boron neutron capture therapy and the use thereof | Pending | 26-Sep-2022 | ||
| US-20230144805-A1 | Methods of noninvasive detection and specific treatment for cancer metastasis | Pending | 10-Nov-2021 |
Primo Biotechnology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Paragon Investment | Venture Capital | Minority | ||
| AVA Angels | Angel Group | Minority |
Primo Biotechnology FAQs
-
When was Primo Biotechnology founded?
Primo Biotechnology was founded in 2021.
-
Where is Primo Biotechnology headquartered?
Primo Biotechnology is headquartered in Taipei City, Taiwan.
-
What industry is Primo Biotechnology in?
Primo Biotechnology’s primary industry is Diagnostic Equipment.
-
Is Primo Biotechnology a private or public company?
Primo Biotechnology is a Private company.
-
What is Primo Biotechnology’s current revenue?
The current revenue for Primo Biotechnology is .
-
How much funding has Primo Biotechnology raised over time?
Primo Biotechnology has raised $9.9M.
-
Who are Primo Biotechnology’s investors?
Paragon Investment and AVA Angels have invested in Primo Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process